301 related articles for article (PubMed ID: 19646600)
1. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
Peccatori F; Demeestere I
Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
[No Abstract] [Full Text] [Related]
2. Questioning GnRH analogs for gonadal protection in cancer patients.
Oktay K; Sönmezer M
Fertil Steril; 2009 Aug; 92(2):e32; author reply e34. PubMed ID: 19646599
[No Abstract] [Full Text] [Related]
3. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
Badawy A; Elnashar A; El-Ashry M; Shahat M
Fertil Steril; 2009 Mar; 91(3):694-7. PubMed ID: 18675959
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
[TBL] [Abstract][Full Text] [Related]
5. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
7. Ovarian function preservation by GnRH agonists during chemotherapy.
Blumenfeld Z
J Womens Health (Larchmt); 2009 Sep; 18(9):1471; author reply 1473. PubMed ID: 19708807
[No Abstract] [Full Text] [Related]
8. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
Blumenfeld Z
Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
[TBL] [Abstract][Full Text] [Related]
9. Impact of breast cancer treatment on fertility.
de la Haba-Rodríguez J; Calderay M
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():59-63. PubMed ID: 20711656
[No Abstract] [Full Text] [Related]
10. [Breast cancer and fertility: critical review, considerations and perspectives].
This P
Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
[TBL] [Abstract][Full Text] [Related]
11. New hope for young breast cancer patients.
Peres J
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214565
[No Abstract] [Full Text] [Related]
12. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
Franke HR; Smit WM; Vermes I
Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
Imai A; Furui T
J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
[TBL] [Abstract][Full Text] [Related]
14. Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy?
Partridge AH
J Clin Oncol; 2012 Feb; 30(5):479-81. PubMed ID: 22231046
[No Abstract] [Full Text] [Related]
15. Reproduction after breast cancer.
Zervoudis S; Iatrakis G; Navrozoglou I
Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):81-6. PubMed ID: 20170848
[TBL] [Abstract][Full Text] [Related]
16. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Blumenfeld Z; von Wolff M
Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
[TBL] [Abstract][Full Text] [Related]
17. Assisted reproduction and breast cancer.
Sonmezer M; Atabekoglu C
Minerva Ginecol; 2007 Aug; 59(4):403-14. PubMed ID: 17923831
[TBL] [Abstract][Full Text] [Related]
18. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.
Potolog-Nahari C; Fishman A; Cohen I
Gynecol Endocrinol; 2007 May; 23(5):290-4. PubMed ID: 17558688
[TBL] [Abstract][Full Text] [Related]
19. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
Yasumura T; Oka T; Honjo H; Okada H
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
